PC Connection Inc. (PCCC) Jumps 10.1% on January 29

Equities Staff |

PC Connection Inc. (PCCC) was among the biggest gainers on the Russell 2000 for Friday January 29 as the stock popped 10.1% to $22.35, representing a gain of $2.05 per share. Some 96,340 shares traded hands on 1,005 trades, compared with an average daily volume of 46,585 shares out of a total float of 26.44 million. The stock opened at $22.29 and traded with an intraday range of $22.98 to $22.01.

After today's gains, PC Connection Inc. reached a market cap of $591.03 million. PC Connection Inc. has had a trading range between $27.39 and $19.19 over the last year, and it had a 50-day SMA of $21.52 and a 200-day SMA of $22.24.

The stock has a P/E Ratio of 12.

PC Connection Inc is a provider of information technology or IT solutions. It provides IT products including computer systems, software and peripheral equipment, networking communications that it purchases from manufacturers and distributors.

PC Connection Inc. is based out of Merrimack, NH and has some 2,047 employees. Its CEO is Timothy J. McGrath.

For a complete fundamental analysis analysis of PC Connection Inc., check out Equities.com’s Stock Valuation Analysis report for PCCC. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

MyForce, Inc.

As parents, we constantly worry about the safety of our loved ones. The media bombards us with incidents from across the nation school shootings, frequent assaults on campuses, and crimes…

Ozobot by Evollve Inc

Ozobot is a world leader in compact super intelligent robots that entertain and educate through fun interactive gaming.